|
US7276497B2
(en)
*
|
2003-05-20 |
2007-10-02 |
Immunogen Inc. |
Cytotoxic agents comprising new maytansinoids
|
|
JP5149620B2
(ja)
|
2004-07-23 |
2013-02-20 |
エンドサイト，インコーポレイテッド |
２価リンカーおよびその結合体
|
|
EP3539572A1
(en)
|
2005-08-24 |
2019-09-18 |
ImmunoGen, Inc. |
Process for preparing maytansinoid antibody conjugates
|
|
NZ580132A
(en)
|
2007-03-14 |
2012-11-30 |
Endocyte Inc |
Binding ligand linked drug delivery conjugates of tubulysins to vitamins
|
|
BRPI0809435A2
(pt)
|
2007-03-27 |
2014-09-09 |
Sea Lane Biotechnologies, Llc |
Constructos e bibliotecas que compreendem sequências de cadeia leve substituida de anticorpos
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
CN104383553A
(zh)
|
2007-06-25 |
2015-03-04 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
RU2487877C2
(ru)
|
2008-04-30 |
2013-07-20 |
Иммьюноджен, Инк. |
Высокоэффективные конъюгаты и гидрофильные сшивающие агенты (линкеры)
|
|
EP2281006B1
(en)
|
2008-04-30 |
2017-08-02 |
Immunogen, Inc. |
Cross-linkers and their uses
|
|
JP2012526839A
(ja)
|
2009-05-13 |
2012-11-01 |
シー レーン バイオテクノロジーズ， エルエルシー |
インフルエンザウイルスに対する中和分子
|
|
EP2437790B1
(en)
|
2009-06-03 |
2019-02-20 |
Immunogen, Inc. |
Conjugation methods
|
|
AU2015201534B2
(en)
*
|
2009-06-03 |
2016-11-24 |
Immunogen, Inc. |
Conjugation methods
|
|
FR2947269B1
(fr)
|
2009-06-29 |
2013-01-18 |
Sanofi Aventis |
Nouveaux composes anticancereux
|
|
FR2949469A1
(fr)
*
|
2009-08-25 |
2011-03-04 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application en therapeutique
|
|
JP2013504585A
(ja)
*
|
2009-09-09 |
2013-02-07 |
セントローズ， エルエルシー |
細胞外標的化薬物複合体
|
|
UY32913A
(es)
*
|
2009-10-02 |
2011-04-29 |
Sanofi Aventis |
Nuevos maitansinoides y el uso de dichos maitansinoides para preparar conjugados con un anticuero
|
|
JP2013506709A
(ja)
*
|
2009-10-06 |
2013-02-28 |
イミュノジェン・インコーポレーテッド |
有効なコンジュゲートおよび親水性リンカー
|
|
AR080301A1
(es)
|
2010-02-24 |
2012-03-28 |
Immunogen Inc |
Anticuerpos e inmunoconjugados del receptor 1 de folato y sus usos
|
|
MX338932B
(es)
|
2010-03-12 |
2016-05-06 |
Immunogen Inc |
Moleculas de union cd37 y sus inmunoconjugados.
|
|
FR2963007B1
(fr)
|
2010-07-26 |
2013-04-05 |
Sanofi Aventis |
Derives anticancereux, leur preparation et leur application therapeutique
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
TW201302793A
(zh)
|
2010-09-03 |
2013-01-16 |
Glaxo Group Ltd |
新穎之抗原結合蛋白
|
|
KR20140008308A
(ko)
|
2010-10-29 |
2014-01-21 |
이뮤노젠 아이엔씨 |
신규한 egfr-결합 분자 및 이의 면역컨쥬게이트
|
|
CN103328505B
(zh)
|
2010-10-29 |
2015-12-02 |
伊缪诺金公司 |
非拮抗性egfr结合分子及其免疫偶联物
|
|
JP2013542958A
(ja)
*
|
2010-11-03 |
2013-11-28 |
イミュノジェン・インコーポレーテッド |
アンサマイトシン誘導体を含む細胞傷害性剤
|
|
WO2012074757A1
(en)
*
|
2010-11-17 |
2012-06-07 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
|
CN107011253B
(zh)
|
2010-12-09 |
2021-01-15 |
伊缪诺金公司 |
制备带电荷交联剂的方法
|
|
KR20140010076A
(ko)
|
2011-02-15 |
2014-01-23 |
이뮤노젠 아이엔씨 |
세포독성 벤조다이아제핀 유도체
|
|
JP2014510080A
(ja)
*
|
2011-03-09 |
2014-04-24 |
セントローズ， エルエルシー |
細胞外標的化薬物複合体
|
|
WO2012135517A2
(en)
|
2011-03-29 |
2012-10-04 |
Immunogen, Inc. |
Preparation of maytansinoid antibody conjugates by a one-step process
|
|
TR201902180T4
(tr)
|
2011-03-29 |
2019-03-21 |
Immunogen Inc |
Tek adimli bi̇r i̇şlem i̇le maytansi̇noi̇d anti̇kor konjugatlarinin hazirlanmasi
|
|
PL2694106T3
(pl)
|
2011-04-01 |
2018-06-29 |
Immunogen, Inc. |
Sposoby zwiększania skuteczności terapii przeciwnowotworowej opartej na receptorze folr1
|
|
US20120282282A1
(en)
*
|
2011-04-04 |
2012-11-08 |
Immunogen, Inc. |
Methods for Decreasing Ocular Toxicity of Antibody Drug Conjugates
|
|
US9475879B2
(en)
|
2011-04-21 |
2016-10-25 |
Bristol-Myers Squibb Company |
Antibody polypeptides that antagonize CD40
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CA2837840C
(en)
|
2011-06-10 |
2020-08-04 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
EP2736928B1
(en)
|
2011-07-28 |
2019-01-09 |
i2 Pharmaceuticals, Inc. |
Sur-binding proteins against erbb3
|
|
KR20140105765A
(ko)
|
2011-11-21 |
2014-09-02 |
이뮤노젠 아이엔씨 |
EGfr 항체 세포독성제 접합체에 의한 EGfr 치료에 내성을 나타내는 종양의 치료 방법
|
|
EP2793940B1
(en)
|
2011-12-22 |
2018-11-14 |
i2 Pharmaceuticals, Inc. |
Surrogate binding proteins
|
|
CN104023751B
(zh)
*
|
2012-01-27 |
2016-11-09 |
弗·哈夫曼-拉罗切有限公司 |
靶向递送至表达vla-4的细胞的整联蛋白拮抗剂结合物
|
|
US10080805B2
(en)
|
2012-02-24 |
2018-09-25 |
Purdue Research Foundation |
Cholecystokinin B receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
KR20150046316A
(ko)
|
2012-08-31 |
2015-04-29 |
이뮤노젠 아이엔씨 |
엽산 수용체 1의 검출을 위한 진단성 검정 및 키트
|
|
RU2661083C2
(ru)
|
2012-10-04 |
2018-07-11 |
Иммуноджен, Инк. |
Использование пвдф-мембраны для очистки конъюгатов клеточно-связывающий агент - цитотоксический агент
|
|
WO2014055842A1
(en)
*
|
2012-10-04 |
2014-04-10 |
Immunogen, Inc. |
Process for preparing stable antibody maytansinoid conjugates
|
|
JP2015536323A
(ja)
|
2012-10-16 |
2015-12-21 |
エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． |
非天然アミノ酸を含む薬物送達結合体および使用方法
|
|
US20150290342A1
(en)
*
|
2012-10-24 |
2015-10-15 |
Polytherics Limited |
Drug-protein conjugates
|
|
NO2789793T3
(enExample)
*
|
2012-10-24 |
2018-01-27 |
|
|
|
AU2012395148B2
(en)
|
2012-11-24 |
2016-10-27 |
Hangzhou Dac Biotech Co., Ltd. |
Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules
|
|
WO2014089177A2
(en)
|
2012-12-04 |
2014-06-12 |
Massachusetts Institute Of Technology |
Compounds, conjugates and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines
|
|
CN103288957B
(zh)
|
2012-12-21 |
2015-01-28 |
百奥泰生物科技(广州)有限公司 |
一种抑制肿瘤生长的抗体药物衍生物及其制备方法和用途
|
|
CN104650113A
(zh)
*
|
2012-12-21 |
2015-05-27 |
百奥泰生物科技(广州)有限公司 |
类美登素衍生物及其制备方法和用途
|
|
US9968673B2
(en)
*
|
2013-02-26 |
2018-05-15 |
Commissariat á l'ènergie atomique et aux ènergies alternatives |
Immunogenic composition in emulsion form comprising two dispersed phases, one comprising an antigen and the other comprising an immunostimulating agent
|
|
FR3002454B1
(fr)
*
|
2013-02-26 |
2015-04-10 |
Commissariat Energie Atomique |
Composition immunogene sous forme d'emulsion
|
|
HK1219422A1
(zh)
*
|
2013-02-28 |
2017-04-07 |
Immunogen, Inc. |
包含细胞结合剂及细胞毒素剂的轭合物
|
|
EP3964237B1
(en)
|
2013-03-15 |
2026-02-18 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecules, conjugates thereof, and therapeutic uses
|
|
US9522876B2
(en)
|
2013-03-15 |
2016-12-20 |
Zymeworks Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
JP6207721B2
(ja)
*
|
2013-05-02 |
2017-10-04 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
アフコシル化ｃｄ２０抗体のｃｄ２２抗体−薬物コンジュゲートとの併用療法
|
|
US10208125B2
(en)
|
2013-07-15 |
2019-02-19 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Anti-mucin 1 binding agents and uses thereof
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
KR102252925B1
(ko)
|
2013-08-26 |
2021-05-18 |
리제너론 파마슈티칼스 인코포레이티드 |
마크롤라이드 디아스테레오머를 포함하는 약제학적 조성물, 이의 합성 방법 및 치료학적 용도
|
|
PT3038650T
(pt)
|
2013-08-30 |
2021-08-25 |
Immunogen Inc |
Anticorpos e ensaios para a deteção do recetor de folato 1
|
|
SG10201801779XA
(en)
|
2013-09-05 |
2018-04-27 |
Jackson Lab |
Compositions for rna-chromatin interaction analysis and uses thereof
|
|
NZ757964A
(en)
|
2013-10-08 |
2022-07-01 |
Immunogen Inc |
Anti-folr1 immunoconjugate dosing regimens
|
|
KR102087850B1
(ko)
|
2013-10-11 |
2020-03-12 |
메르사나 테라퓨틱스, 인코포레이티드 |
단백질-고분자-약물 접합체
|
|
KR102572149B1
(ko)
|
2013-10-11 |
2023-08-30 |
아사나 바이오사이언시스 엘엘씨 |
단백질-폴리머-약물 접합체
|
|
CN103483357B
(zh)
*
|
2013-10-12 |
2015-11-18 |
齐鲁制药有限公司 |
一种抗体-美登素偶联物的中间体新晶型及其制备方法
|
|
CN105793268B
(zh)
*
|
2013-12-02 |
2019-03-15 |
香港浸会大学 |
具有两个稠合大环的抗癌性美登木素类化合物
|
|
ES2916722T3
(es)
|
2013-12-27 |
2022-07-05 |
Zymeworks Inc |
Sistemas de enlace que contienen sulfonamida para conjugados de fármacos
|
|
RU2685728C2
(ru)
*
|
2014-01-29 |
2019-04-23 |
Шанхай Хэнжуй Фармасьютикал Ко., Лтд. |
Конъюгат лиганд - цитотоксическое лекарственное средство, способ его получения и его применения
|
|
MY178160A
(en)
|
2014-03-11 |
2020-10-06 |
Regeneron Pharma |
Anti-egfrviii antibodies and uses thereof
|
|
CA2943952A1
(en)
*
|
2014-03-24 |
2015-10-01 |
The Trustees Of Columbia University In The City Of New York |
Chemical methods for producing tagged nucleotides
|
|
EP3517114A1
(en)
*
|
2014-04-29 |
2019-07-31 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
New stable antibody-drug conjugate, preparation method and use thereof
|
|
EP3160513B1
(en)
|
2014-06-30 |
2020-02-12 |
Glykos Finland Oy |
Saccharide derivative of a toxic payload and antibody conjugates thereof
|
|
WO2016004048A2
(en)
|
2014-06-30 |
2016-01-07 |
Blend Therapeutics, Inc. |
Targeted conjugates and particles and formulations thereof
|
|
AU2015311951B2
(en)
|
2014-09-02 |
2021-04-08 |
Immunogen, Inc. |
Methods for formulating antibody drug conjugate compositions
|
|
TW201609152A
(zh)
|
2014-09-03 |
2016-03-16 |
免疫原公司 |
包含細胞結合劑及細胞毒性劑之偶聯物
|
|
TW201613930A
(en)
|
2014-09-03 |
2016-04-16 |
Immunogen Inc |
Cytotoxic benzodiazepine derivatives
|
|
PT3189056T
(pt)
|
2014-09-03 |
2020-09-04 |
Immunogen Inc |
Derivados citotóxicos de benzodiazepina
|
|
EP3194421B1
(en)
|
2014-09-17 |
2021-11-03 |
Zymeworks Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
KR20240142591A
(ko)
|
2015-03-27 |
2024-09-30 |
리제너론 파아마슈티컬스, 인크. |
메이탄시노이드 유도체, 이의 컨주게이트, 및 사용 방법
|
|
SG10202110908WA
(en)
|
2015-05-04 |
2021-11-29 |
Cytomx Therapeutics Inc |
Anti-cd166 antibodies, activatable anti-cd166 antibodies, and methods of use thereof
|
|
CN106243127B
(zh)
*
|
2015-06-09 |
2021-01-26 |
凯惠科技发展(上海)有限公司 |
抗体药物偶联物、中间体、制备方法、药物组合物及应用
|
|
MD3313845T2
(ro)
|
2015-06-29 |
2021-02-28 |
Immunogen Inc |
Conjugați cu anticorpi având cisteină modificată prin inginerie genetică
|
|
EP3317246A4
(en)
*
|
2015-07-04 |
2019-02-27 |
Suzhou M-conj Biotech Co., Ltd. |
SPECIFIC CONJUGATION OF A CELL BINDING MOLECULE
|
|
MY189159A
(en)
|
2015-07-06 |
2022-01-29 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
SMT202000004T1
(it)
|
2015-07-21 |
2020-03-13 |
Immunogen Inc |
Metodi di preparazione dei derivati citotossici di benzodiazepina
|
|
EP3331569A1
(en)
|
2015-08-07 |
2018-06-13 |
Gamamabs Pharma |
Antibodies, antibody drug conjugates and methods of use
|
|
JP6880006B2
(ja)
|
2015-09-17 |
2021-06-02 |
イミュノジェン， インコーポレイテッド |
抗ｆｏｌｒ１免疫複合体を含む治療組み合わせ
|
|
HK1259311A1
(zh)
|
2015-10-28 |
2019-11-29 |
Tva (Abc), Llc |
Sstr靶向綴合物及其顆粒和製劑
|
|
SG11201803915UA
(en)
|
2015-11-10 |
2018-06-28 |
Childrens Research Institute Childrens National Medical Center |
Echinomycin formulation, method of making and method of use thereof
|
|
US20170189548A1
(en)
|
2015-11-25 |
2017-07-06 |
Immunogen, Inc. |
Pharmaceutical formulations and methods of use thereof
|
|
CN108602890A
(zh)
|
2015-12-11 |
2018-09-28 |
瑞泽恩制药公司 |
用于减少或预防对egfr和/或erbb3阻滞剂具有抗性的肿瘤生长的方法
|
|
MY198605A
(en)
|
2016-01-25 |
2023-09-08 |
Regeneron Pharma |
Maytansinoid derivatives conjugates thereof, and methods of use
|
|
MA45280B1
(fr)
*
|
2016-03-02 |
2021-08-31 |
Eisai R&D Man Co Ltd |
Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation
|
|
JP6937773B2
(ja)
|
2016-03-07 |
2021-09-22 |
ハンミ ファーマシューティカル カンパニー リミテッド |
ポリエチレングリコール誘導体及びその用途
|
|
WO2017190079A1
(en)
|
2016-04-28 |
2017-11-02 |
Regeneron Pharmaceuticals, Inc. |
Methods of making multispecific antigen-binding molecules
|
|
US10918627B2
(en)
|
2016-05-11 |
2021-02-16 |
Massachusetts Institute Of Technology |
Convergent and enantioselective total synthesis of Communesin analogs
|
|
TWI762487B
(zh)
|
2016-06-08 |
2022-05-01 |
美商艾伯維有限公司 |
抗-b7-h3抗體及抗體藥物結合物
|
|
JP2019524687A
(ja)
|
2016-07-01 |
2019-09-05 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
抗体薬物複合体およびこれを用いた治療方法
|
|
RU2653443C2
(ru)
*
|
2016-07-15 |
2018-05-08 |
Закрытое Акционерное Общество "Биокад" |
Биспецифичные анти-her2/анти-her3 антитела
|
|
MA46417A
(fr)
|
2016-09-23 |
2019-07-31 |
Regeneron Pharma |
Anticorps anti-steap2, conjugués anticorps-médicament, et molécules bispécifiques de liaison à l'antigène qui se lient à steap2 et cd3, et leurs utilisations
|
|
US10738130B2
(en)
|
2016-09-23 |
2020-08-11 |
Regeneron Pharmaceuticals, Inc. |
Bispecific antigen-binding molecules that bind MUC16 and CD3, and compositions thereof
|
|
KR20250114431A
(ko)
|
2016-11-08 |
2025-07-29 |
리제너론 파마슈티칼스 인코포레이티드 |
스테로이드 및 이의 단백질-접합체
|
|
TWI782930B
(zh)
|
2016-11-16 |
2022-11-11 |
美商再生元醫藥公司 |
抗ｍｅｔ抗體，結合ｍｅｔ之雙特異性抗原結合分子及其使用方法
|
|
TWI755450B
(zh)
|
2016-11-23 |
2022-02-21 |
美商伊繆諾金公司 |
苯二氮平衍生物之選擇性磺化
|
|
EP3548514A1
(en)
|
2016-11-29 |
2019-10-09 |
Regeneron Pharmaceuticals, Inc. |
Methods of treating prlr positive breast cancer
|
|
JP7350313B2
(ja)
|
2016-12-16 |
2023-09-26 |
ブルーフィン バイオメディシン， インコーポレイテッド |
抗ｃｕｂドメイン含有タンパク質１（ｃｄｃｐ１）抗体、抗体薬物コンジュゲート、およびその使用方法
|
|
SI3558391T1
(sl)
|
2016-12-23 |
2022-06-30 |
Immunogen, Inc. |
Imunokonjugati, ciljno usmerjeni na ADAM9, in načini njihove uporabe
|
|
US20180230218A1
(en)
|
2017-01-04 |
2018-08-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
CN116785450A
(zh)
|
2017-02-28 |
2023-09-22 |
伊缪诺金公司 |
具有自分解肽接头的类美登素衍生物和其缀合物
|
|
WO2018159582A1
(ja)
|
2017-02-28 |
2018-09-07 |
学校法人近畿大学 |
抗ｈｅｒ３抗体－薬物コンジュゲート投与によるｅｇｆｒ－ｔｋｉ抵抗性の非小細胞肺癌の治療方法
|
|
EP3381474A1
(en)
*
|
2017-03-27 |
2018-10-03 |
Alfasigma S.p.A. |
Histone deacetylase inhibitors-based antibody drug conjugates (adcs) and use in therapy
|
|
EP3604385B1
(en)
*
|
2017-03-30 |
2024-05-01 |
NOF Corporation |
Heterobifunctional monodispersed polyethylene glycol and conjugate using the same
|
|
TW201839001A
(zh)
|
2017-04-20 |
2018-11-01 |
美商伊繆諾金公司 |
細胞毒性苯并二氮平衍生物及其綴合物
|
|
US11932650B2
(en)
|
2017-05-11 |
2024-03-19 |
Massachusetts Institute Of Technology |
Potent agelastatin derivatives as modulators for cancer invasion and metastasis
|
|
KR20200007905A
(ko)
|
2017-05-18 |
2020-01-22 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
AU2018269568B2
(en)
|
2017-05-18 |
2022-03-24 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
ES3065816T3
(en)
|
2017-06-07 |
2026-05-08 |
Regeneron Pharma |
Compositions and methods for internalizing enzymes
|
|
EP4509143A3
(en)
*
|
2017-06-20 |
2025-04-23 |
Sorrento Therapeutics, Inc. |
Cd38 antibody drug conjugate
|
|
US10640508B2
(en)
|
2017-10-13 |
2020-05-05 |
Massachusetts Institute Of Technology |
Diazene directed modular synthesis of compounds with quaternary carbon centers
|
|
IL313068A
(en)
|
2017-11-07 |
2024-07-01 |
Regeneron Pharma |
Hydrophilic linkers for antibody drug conjugates
|
|
CN109771658B
(zh)
*
|
2017-11-14 |
2021-12-10 |
博瑞生物医药（苏州）股份有限公司 |
靶向多臂偶联物
|
|
EP3732178A1
(en)
|
2017-12-28 |
2020-11-04 |
ImmunoGen, Inc. |
Benzodiazepine derivatives
|
|
IL275757B2
(en)
|
2018-01-08 |
2025-08-01 |
Regeneron Pharma |
Steroids and antibody-conjugates thereof
|
|
CA3087993A1
(en)
*
|
2018-01-12 |
2019-07-18 |
Immunogen, Inc. |
Methods for antibody drug conjugation, purification, and formulation
|
|
CN112074538B
(zh)
|
2018-04-30 |
2024-10-18 |
瑞泽恩制药公司 |
结合her2和/或aplp2的抗体和双特异性抗原结合分子、其缀合物和用途
|
|
MX2020011546A
(es)
|
2018-05-09 |
2021-01-29 |
Regeneron Pharma |
Anticuerpos anti-msr1 y metodos de uso de los mismos.
|
|
BR112020023145A2
(pt)
|
2018-05-17 |
2021-02-02 |
Regeneron Pharmaceuticals, Inc. |
anticorpo anti-cd63 ou fragmento de ligação ao antígeno do mesmo, molécula de ligação ao antígeno biespecífica, proteína terapêutica de múltiplos domínios, polinucleotídeo composição farmacêutica, e, composto
|
|
MX2020013466A
(es)
|
2018-06-26 |
2021-04-19 |
Immunogen Inc |
Inmunoconjugados dirigidos a adam9 y métodos para usarlos.
|
|
WO2020014306A1
(en)
|
2018-07-10 |
2020-01-16 |
Immunogen, Inc. |
Met antibodies and immunoconjugates and uses thereof
|
|
CN112912109A
(zh)
|
2018-09-20 |
2021-06-04 |
第一三共株式会社 |
通过施用抗her3抗体-药物缀合物治疗her3-突变的癌症
|
|
CN109350748B
(zh)
*
|
2018-10-24 |
2021-06-11 |
沈阳药科大学 |
氧化还原双敏感键桥连小分子前药及其自组装纳米粒
|
|
TWI897855B
(zh)
|
2018-10-26 |
2025-09-21 |
美商免疫遺傳股份有限公司 |
Ｅ ｐ Ｃ Ａ Ｍ 抗體、可活化抗體及免疫偶聯物以及其用途
|
|
SG11202105175WA
(en)
|
2018-11-20 |
2021-06-29 |
Regeneron Pharma |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
CA3123607A1
(en)
|
2018-12-21 |
2020-06-25 |
Regeneron Pharmaceuticals, Inc. |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
CN118027137A
(zh)
|
2018-12-21 |
2024-05-14 |
里珍纳龙药品有限公司 |
微管溶素及蛋白质-微管溶素偶联物
|
|
WO2020146541A2
(en)
|
2019-01-08 |
2020-07-16 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
|
MX2021010114A
(es)
|
2019-02-21 |
2021-12-10 |
Regeneron Pharma |
Métodos para tratar el cáncer ocular mediante el uso de anticuerpos anti-met y moléculas de unión a antígeno bispecíficas que se unen a met.
|
|
SG11202109986TA
(en)
|
2019-03-20 |
2021-10-28 |
Univ California |
Claudin-6 antibodies and drug conjugates
|
|
WO2020191344A1
(en)
|
2019-03-20 |
2020-09-24 |
The Regents Of The University Of California |
Claudin-6 bispecific antibodies
|
|
EP3947395A1
(en)
|
2019-03-29 |
2022-02-09 |
ImmunoGen, Inc. |
Cytotoxic bis-benzodiazepine derivatives and conjugates thereof with cell-binding agents for inhibiting abnormal cell growth or for treating proliferative diseases
|
|
HUE065484T2
(hu)
|
2019-04-26 |
2024-05-28 |
Immunogen Inc |
Camptothecin-származékok
|
|
US11535634B2
(en)
|
2019-06-05 |
2022-12-27 |
Massachusetts Institute Of Technology |
Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof
|
|
PH12022550037A1
(en)
|
2019-07-10 |
2023-04-12 |
Cybrexa 3 Inc |
Peptide conjugates of microtubule-targeting agents as therapeutics
|
|
KR20220052918A
(ko)
|
2019-07-10 |
2022-04-28 |
싸이브렉사 2, 인크. |
치료제로서의 사이토톡신의 펩티드 접합체
|
|
JP7750828B2
(ja)
|
2019-09-16 |
2025-10-07 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
免疫ｐｅｔ撮像のための放射標識されたｍｅｔ結合タンパク質
|
|
US11814428B2
(en)
|
2019-09-19 |
2023-11-14 |
Regeneron Pharmaceuticals, Inc. |
Anti-PTCRA antibody-drug conjugates and uses thereof
|
|
BR112022014278A2
(pt)
|
2020-01-24 |
2022-09-20 |
Regeneron Pharma |
Conjugados de composto proteico-antiviral
|
|
BR112022017064A2
(pt)
|
2020-02-25 |
2022-11-16 |
Mediboston Inc |
Derivados da camptotecina e seus conjugados
|
|
IL295312A
(en)
|
2020-02-28 |
2022-10-01 |
Regeneron Pharma |
Bispecific antigen binding molecules that bind her2, and methods of use thereof
|
|
JP2023521885A
(ja)
|
2020-04-16 |
2023-05-25 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ディールス－アルダーコンジュゲーション方法
|
|
EP4171653A2
(en)
|
2020-06-24 |
2023-05-03 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
US20230256114A1
(en)
|
2020-07-07 |
2023-08-17 |
Bionecure Therapeutics, Inc. |
Novel maytansinoids as adc payloads and their use for the treatment of cancer
|
|
US12605459B2
(en)
|
2020-07-13 |
2026-04-21 |
Regeneron Pharmaceuticals, Inc. |
Protein-drug conjugates comprising camptothecin analogs and methods of use thereof
|
|
US20230277679A1
(en)
|
2020-07-17 |
2023-09-07 |
Daiichi Sankyo Company, Limited |
Method for producing antibody-drug conjugate
|
|
MX2023002974A
(es)
|
2020-09-14 |
2023-05-25 |
Regeneron Pharma |
Conjugados de anticuerpo-farmaco que comprenden peptidomimeticos glp1 y usos de los mismos.
|
|
CA3190569A1
(en)
|
2020-10-22 |
2022-04-28 |
Christopher Daly |
Anti-fgfr2 antibodies and methods of use thereof
|
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
|
US12030888B2
(en)
|
2021-02-24 |
2024-07-09 |
Massachusetts Institute Of Technology |
Himastatin derivatives, and processes of preparation thereof, and uses thereof
|
|
US12521444B2
(en)
|
2021-02-25 |
2026-01-13 |
Fortvita Biologics Limited |
Anti-HER2 antibody-drug conjugates and uses thereof
|
|
CN117042806A
(zh)
|
2021-03-08 |
2023-11-10 |
启德医药科技（苏州）有限公司 |
抗体-免疫激动剂缀合物及其应用
|
|
AU2022259314A1
(en)
|
2021-04-14 |
2023-11-30 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Linkers, conjugates and applications thereof
|
|
KR20240038928A
(ko)
|
2021-07-28 |
2024-03-26 |
리제너론 파마슈티칼스 인코포레이티드 |
단백질-항바이러스 화합물 접합체
|
|
EP4389804A4
(en)
*
|
2021-08-20 |
2025-10-08 |
Nat Univ Pusan Ind Univ Coop Found |
PROCESS FOR PREPARING A SWELLABLE POLYMER TO WHICH AN OBJECT IS ATTACHED
|
|
CN118541173A
(zh)
*
|
2021-12-15 |
2024-08-23 |
图兰恩教育基金管理人 |
缀合物、其组合物及其相关方法
|
|
US20230414775A1
(en)
|
2021-12-29 |
2023-12-28 |
Regeneron Pharmaceuticals, Inc. |
Tubulysins and protein-tubulysin conjugates
|
|
CN118829449A
(zh)
|
2022-01-12 |
2024-10-22 |
瑞泽恩制药公司 |
与蛋白中的谷氨酰胺残基缀合的喜树碱类似物及其用途
|
|
CA3242639A1
(en)
|
2022-01-14 |
2023-07-20 |
Regeneron Pharmaceuticals, Inc. |
Verrucarin A derivatives and their antibody-drug conjugates
|
|
AU2023231305A1
(en)
|
2022-03-11 |
2024-09-12 |
Regeneron Pharmaceuticals, Inc. |
Anti-GLP1r antibody-tethered drug conjugates comprising GLP1 peptidomimetics and uses thereof
|
|
KR20250069711A
(ko)
|
2022-07-21 |
2025-05-19 |
파이어플라이 바이오, 인크. |
글루코코르티코이드 수용체 작용제 및 이의 접합체
|
|
JP2025524986A
(ja)
|
2022-07-27 |
2025-08-01 |
メディボストン リミテッド |
オーリスタチン誘導体およびそのコンジュゲート
|
|
CN120659785A
(zh)
|
2022-11-30 |
2025-09-16 |
里珍纳龙药品有限公司 |
Tlr7激动剂及其抗体-药物缀合物
|
|
CN120752059A
(zh)
|
2022-12-21 |
2025-10-03 |
瑞泽恩制药公司 |
用于adc缀合的拓扑异构酶i抑制剂的前药及其使用方法
|
|
EP4661914A1
(en)
|
2023-02-09 |
2025-12-17 |
Regeneron Pharmaceuticals, Inc. |
Antibody-drug conjugates via inverse electron demand diels-alder reactions
|
|
WO2024220628A1
(en)
*
|
2023-04-18 |
2024-10-24 |
The Regents Of The University Of Colorado, A Body Corporate |
Target for combatting the foreign body response to implantable biomaterials
|
|
CN121039163A
(zh)
|
2023-05-02 |
2025-11-28 |
瑞泽恩制药公司 |
抗人m-钙粘蛋白（cdh15）抗体、缀合物及其用于将遗传有效负载递送至肌肉细胞的用途
|
|
CN121219016A
(zh)
|
2023-06-02 |
2025-12-26 |
第一三共株式会社 |
抗-her3抗体-药物缀合物和rasg12c抑制剂的组合
|
|
IL325400A
(en)
|
2023-07-10 |
2026-02-01 |
Regeneron Pharma |
Anti-human CACNG1 antibody-drug conjugates and their uses
|
|
WO2025094146A1
(en)
|
2023-11-02 |
2025-05-08 |
Immunogen Switzerland Gmbh |
Vasconstrictors for reducing ocular toxicity of antibody-maytansinoid conjugates
|
|
US20250171516A1
(en)
|
2023-11-03 |
2025-05-29 |
Regeneron Pharmaceuticals, Inc. |
Peptide acids as a glp1r agonist and antibody-drug conjugates thereof
|
|
WO2025117727A1
(en)
|
2023-11-29 |
2025-06-05 |
Regeneron Pharmaceuticals, Inc. |
Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses thereof
|
|
CN118580194A
(zh)
*
|
2024-05-21 |
2024-09-03 |
南方科技大学 |
一种双功能分子探针的制备方法
|
|
WO2026020031A2
(en)
|
2024-07-18 |
2026-01-22 |
Novarock Biotherapeutics, Ltd. |
Cdh17 antibodies and uses thereof
|
|
WO2026021443A1
(en)
|
2024-07-23 |
2026-01-29 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Antibody-drug conjugates targeting cdh3 and preparation methods and uses thereof
|